https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Diabetes-MS.jpg

Diabetes Market Size, Share & Trends Analysis | Global (United States and Europe) | 2019-2025 | MedSuite Series | Segmented by: Insulin Syringes, Insulin Pumps, Insulin Pens, and 6 more

  • Year: 2019
  • Scope: 2015-2025
  • Region: Europe, United States
  • Pages: 754
  • Type: MedSuite

Throughout this medical market research on the U.S. and European diabetes monitoring, treatment, and drug delivery markets, over 90 companies across 16 countries were analyzed. To conduct this research, our comprehensive methodology was utilized to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.

Previously, the U.S. diabetes monitoring, treatment, and drug-delivery market was valued at $15.7 billion. However, an increase is projected over the forecast period to reach approximately $16.4 billion by 2025 at a CAGR of 0.6%. In comparison, Europe’s diabetes monitoring, treatment, and drug-delivery market was valued at  €6.8 billion. Similarly, the European market is expected to increase at a CAGR of 4.3% to exceed €9 billion by 2025.

The following segments for both the U.S. and the European diabetes markets are included within this MedSuite series: blood glucose meters, blood glucose test strips, lancets, continuous glucose monitoring (CGM), flash glucose monitoring (FGM), insulin, insulin pens, insulin syringes, and insulin pumps.

MARKET DATA INCLUDED

  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Market Drivers & Limiters
  • Market Forecasts Until 2025, and Historical Data to 2015
  • Recent Mergers & Acquisitions
  • Company Profiles and Product Portfolios
  • Leading Competitors

U.S. DIABETES CARE MARKET INSIGHTSU.S. Diabetes Market by Segment

Although the number of insulin-dependent diabetics is rising in the United States, which has continued to drive unit sales growth of the insulin market, insulin manufacturers have experienced tremendous backlash from consumers and diabetes associations regarding the unreasonable rise in insulin prices over the last several decades. Insulin prices in the United States are among the highest in the world, which has forced patients to extend the usage life of their insulin and choose cost-sensitive therapy options, such as human insulin. As a result, insulin prices are projected to decrease over the forecast period.

EUROPE’S DIABETES CARE MARKET INSIGHTS

Europe Diabetes Care Market GrowthGrowth is expected over the forecast period for the European market, driven by increasing unit sales and moderated by ASP depreciation.  The primary driver of growth will be the expanding diabetic population in Europe and the increasing number of patients that require various diabetes care devices to manage their disease on a daily basis. The largest segment was the insulin market, accounting for approximately 44% of the total market value. The insulin market includes long-acting insulin, ultra-long-acting insulin, rapid-acting insulin, premixed insulin, and human insulin.

U.S. and EUROPEAN DIABETES CARE MARKET SHARE INSIGHTS

Novo NordiskEli Lilly, and Sanofi controlled the U.S. diabetes care market. Novo Nordisk, Sanofi, and Roche led the European diabetes care market. U.S. and European Top Companies in Diabetes Care Market

Within both the U.S. and European markets, Novo Nordisk held the leading position in the ultra-long-acting insulin rapid-acting insulin markets and the second-leading position in the long-acting insulin, premixed insulin, and human insulin markets.

Report Regional Coverage

Throughout this research series, iData has covered several countries in great detail. The covered countries are:

  • North America (United States)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Benelux (Belgium, Netherlands, and Luxembourg), Scandinavia (Denmark, Finland, Norway, and Sweden), Austria, Switzerland, and Portugal)

 

FREE Sample Report

For a Full Table of Contents From Any of the Country Reports in this Global Series, please Contact iData

TABLE OF CONTENTS

LIST OF FIGURES VII LIST OF CHARTS XI EXECUTIVE SUMMARY 1

U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW

COMPETITIVE ANALYSIS 4 MARKET TRENDS 7 MARKET DEVELOPMENTS 9 PROCEDURE NUMBERS 10 PROCEDURE CODES INVESTIGATED 11 MARKETS INCLUDED 12 KEY REPORT UPDATES 14 VERSION HISTORY 14

RESEARCH METHODOLOGY

1.1 RESEARCH SCOPE 15 1.2 IDATA’S 9-STEP METHODOLOGY 15 Step 1: Project Initiation & Team Selection 15 Step 2: Prepare Data Systems and Perform Secondary Research 17 Step 3: Preparation for Interviews & Questionnaire Design 18 Step 4: Performing Primary Research 19 Step 5: Research Analysis: Establishing Baseline Estimates 21 Step 6: Market Forecast and Analysis 22 Step 7: Identify Strategic Opportunities 24 Step 8: Final Review and Market Release 25 Step 9: Customer Feedback and Market Monitoring 26

DISEASE OVERVIEW

2.1 INTRODUCTION 27 2.1.1 Types of Diabetes 27 2.1.2 Diabetes Complications 29 2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 31 2.1.4 Signs and Symptoms 32 2.1.5 Diabetes Monitoring 34 2.1.6 Treatment 36 2.1.7 Drug Delivery Systems 37

U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW

3.1 MARKET OVERVIEW 39 3.2 TREND ANALYSIS 45 3.3 DRIVERS AND LIMITERS 49 3.3.1 Market Drivers 49 3.3.2 Market Limiters 50 3.4 COMPETITIVE MARKET SHARE ANALYSIS 53 3.5 MERGERS AND ACQUISITIONS 57

BLOOD GLUCOSE METER MARKET

4.1 INTRODUCTION 58 4.2 MARKET OVERVIEW 60 4.3 MARKET ANALYSIS AND FORECAST 64 4.3.1 Total Blood Glucose Meter Market 64 4.3.1.1 Personal Blood Glucose Meter Market 66 4.3.1.2 Professional Blood Glucose Meter Market 69 4.4 DRIVERS AND LIMITERS 71 4.4.1 Market Drivers 71 4.4.2 Market Limiters 71v4.5 COMPETITIVE MARKET SHARE ANALYSIS 74

BLOOD GLUCOSE TEST STRIP MARKET

5.1 INTRODUCTION 78 5.2 MARKET OVERVIEW 79 5.3 MARKET ANALYSIS AND FORECAST 83 5.3.1 Total Blood Glucose Test Strip Market 83 5.3.2 Total Personal Blood Glucose Test Strip Market 85 5.3.2.1 Medicare/Medicaid Blood Glucose Test Strip Market 89 5.3.2.2 Managed Care Blood Glucose Test Strip Market 91 5.3.2.3 Cash Blood Glucose Test Strip Market 93 5.3.3 Professional Blood Glucose Test Strip Market 95 5.4 DRIVERS AND LIMITERS 97 5.4.1 Market Drivers 97 5.4.2 Market Limiters 98 5.5 COMPETITIVE MARKET SHARE ANALYSIS 100

LANCET AND LANCING DEVICE MARKET

6.1 INTRODUCTION 104 6.2 MARKET OVERVIEW 106 6.3 MARKET ANALYSIS AND FORECAST 109 6.3.1 Total Lancet and Lancing Device Market 109 6.3.1.1 Personal Lancet and Lancing Device Market 111 6.3.1.2 Professional Lancet and Lancing Device Market 114 6.4 DRIVERS AND LIMITERS 116 6.4.1 Market Drivers 116 6.4.2 Market Limiters 116 6.5 COMPETITIVE MARKET SHARE ANALYSIS 119

CONTINUOUS GLUCOSE MONITORING MARKET

7.1 INTRODUCTION 123 7.2 MARKET OVERVIEW 125 7.3 MARKET ANALYSIS AND FORECAST 129 7.3.1 Total Personal Continuous Glucose Monitoring Market 129 7.3.1.1 Personal Continuous Glucose Monitoring Receiver Market 133 7.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market 135 7.3.1.3 Personal Continuous Glucose Monitoring Sensor Market 138 7.3.2 Total Professional Continuous Glucose Monitoring Market 140 7.3.2.1 Professional Continuous Glucose Monitoring System Market 144 7.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market 146 7.3.2.3 Professional Continuous Glucose Monitoring Sensor Market 148 7.3.3 Emerging Markets: Non-Invasive CGM 150 7.4 DRIVERS AND LIMITERS 151 7.4.1 Market Drivers 151 7.4.2 Market Limiters 153 7.5 COMPETITIVE MARKET SHARE ANALYSIS 155

INSULIN MARKET

8.1 INTRODUCTION 159 8.1.1 Insulin Types 159 8.1.1.1 Rapid-Acting Insulin Analogs 159 8.1.1.2 Regular Human Insulin 160 8.1.1.3 Intermediate-Acting Human Insulin 160 8.1.1.4 Long-Acting Insulin Analogs 160 8.1.1.5 Ultra-Long-Acting Insulin Analogs 160 8.1.1.6 Premixed Insulin 160 8.2 MARKET OVERVIEW 162 8.3 MARKET ANALYSIS AND FORECAST 166 8.3.1 Total Insulin Market 166 8.3.1.1 Long-Acting Insulin Market 169 8.3.1.2 Rapid-Acting Insulin Market 172 8.3.1.3 Premixed Insulin Market 175 8.3.1.4 Human Insulin Market 177 8.4 DRIVERS AND LIMITERS 179 8.4.1 Market Drivers 179 8.4.2 Market Limiters 180 8.5 COMPETITIVE MARKET SHARE ANALYSIS 182

INSULIN PEN MARKET

9.1 INTRODUCTION 185 9.2 MARKET OVERVIEW 187 9.3 MARKET ANALYSIS AND FORECAST 191 9.3.1 Prefilled Insulin Pen Market 191 9.3.2 Insulin Pen Cartridge Market 194 9.3.3 Reusable Insulin Pen Market 197 9.3.4 Total Insulin Pen Needle Market 200 9.3.4.1 Conventional Insulin Pen Needle Market 203 9.3.4.2 Safety Insulin Pen Needle Market 206 9.4 DRIVERS AND LIMITERS 208 9.4.1 Market Drivers 208 9.4.2 Market Limiters 210 9.5 COMPETITIVE MARKET SHARE ANALYSIS 212

INSULIN SYRINGE MARKET

10.1 INTRODUCTION 216 10.2 MARKET OVERVIEW 217 10.3 MARKET ANALYSIS AND FORECAST 221 10.3.1 Total Insulin Syringe Market 221 10.3.1.1 Conventional Insulin Syringe Market 224 10.3.1.2 Safety Insulin Syringe Market 227 10.4 DRIVERS AND LIMITERS 230 10.4.1 Market Drivers 230 10.4.2 Market Limiters 230 10.5 COMPETITIVE MARKET SHARE ANALYSIS 234

INSULIN PUMP MARKET

11.1 INTRODUCTION 237 11.1.1 Traditional Insulin Pumps 237 11.1.2 Patch Insulin Pumps 237v11.1.3 Simple Insulin Pumps 238 11.2 MARKET OVERVIEW 239 11.3 MARKET ANALYSIS AND FORECAST 243 11.3.1 Total Traditional Insulin Pump Market 243 11.3.1.1 Traditional Insulin Pump Market 247 11.3.1.2 Infusion Set Market 249 11.3.1.3 Pump Reservoir Market 251 11.3.2 Total Patch Insulin Pump Market 253 11.3.2.1 Patch Pump System Market 257 11.3.2.2 Insulin Pod Market 259 11.3.3 Simple Insulin Pump Market 261 11.4 DRIVERS AND LIMITERS 264 11.4.1 Market Drivers 264 11.4.2 Market Limiters 266 11.5 COMPETITIVE MARKET SHARE ANALYSIS 268 ABBREVIATIONS 272
The Global Report Suite for Diabetes Monitoring, Treatment and Drug Delivery includes analysis on the following companies currently active in this market:
  • Abbott
  • ACON Laboratories
  • AgaMatrix
  • Allison Medical
  • ApexBio
  • Arcadia Group
  • ARKRAY
  • Artsana
  • Ascensia
  • B. Braun
  • Becton Dickinson
  • Bionime
  • Biosense Medical Devices
  • Boehringer Ingelheim
  • Cambridge Sensors
  • CanAm
  • CVS
  • DarioHealth
  • Dexcom
  • Diabetic Supply of Suncoast
  • Eli Lilly
  • Excel International
  • Fifty 50 Medical
  • ForaCare
  • Genesis Health Technologies
  • Gluco Perfect
  • GlucoRx
  • Hekka
  • Home Aide Diagnostics
  • iHealth Labs
  • Infopia
  • Inside Biometrics
  • Insulet
  • Intuity Medical
  • i-SENS
  • Klinion
  • LifeScan
  • Livongo Health
  • Matz Medical
  • McKesson
  • Medicina
  • Medical Plastic Devices
  • MediPurpose
  • Medline
  • Medtronic
  • Menarini
  • Mendor
  • MyGlucoHealth
  • NeedleBay
  • Neon Diagnostics
  • Nipro
  • Nova Biomedical
  • Novo Nordisk
  • Oak Tree Health
  • Omnis Health
  • One Drop
  • Owen Mumford
  • Palmdoc
  • Perrigo
  • Pharma Supply
  • Philosys
  • Platinum Equity
  • Playtex
  • Prodigy
  • Prosum Medical
  • RAYS
  • Retractable Technologies
  • Roche
  • Sanofi
  • SD BIOSENSOR
  • Senseonics
  • Simple Diagnostics
  • Smart Meter
  • Smiths Medical
  • Specialty Medical Supplies
  • Spirit Healthcare
  • SPRINT MOTO
  • STAT Medical Devices
  • Suresign
  • Tandem
  • Telcare
  • Terumo
  • Trivia Health
  • Troge
  • U.S. Diagnostics
  • UltiMed
  • Unilife Medical Solutions
  • Valeritas
  • Vertex Diagnostics
  • Walmart
  • Ypsomed
 

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology